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Abstract Strontium (Sr) ralenate is a new agent used for
the prevention and treatment of osteoporosis. As a bone-
seeking element, 98% of Sr is deposited in the bone and
teeth after oral ingestion. However, the effect of Sr
treatment on bone microarchitecture and bone nanome-
chanical properties remains unclear. In this study, 18
osteoporotic goats were divided into four groups according
to the treatment regimen: control, calcium alone (Ca),
calcium and Sr at 24 mg/kg (Ca+24Sr), and calcium and Sr
at 40 mg/kg (Ca+40Sr). The effects of Sr administration on
bone microarchitecture and nanomechanical properties of
trabecular bones were analyzed with micro-CT and nano-
indentation test, respectively. Serum Sr levels increased six-
and tenfold in the Ca+24Sr and Ca+40Sr groups, respec-
tively. Similarly, Sr in the bone increased four- and sixfold
in these two groups. Sr administration significantly
increased trabecular bone volume fraction, trabecular
thickness, and double-labeled new bone area. Sr adminis-
tration, however, did not significantly change the nano-
mechanical properties of trabecular bone (elastic modulus
and hardness). The data suggested that Sr administration
increased trabecular bone volume and improved the micro-
architecture while maintaining the intrinsic tissue properties




Osteoporosis is characterized by impaired bone quality
which leads to decreased bone strength and increased
susceptibility to fractures. Strontium (Sr)-containing com-
pounds have been reported to exert anabolic effects on the
skeleton when orally administered to animals [1, 2] and
postmenopausal women [3–5]. Treatment with these agents
increases bone mineral content and density, particularly at
skeletal sites that are rich in trabecular bone, such as the
lumbar spine [2, 3, 6, 7]. In humans, studies on the
mechanical properties of bone responsible for the anabolic
action of Sr is mainly achieved by evaluation of fracture
risks [3–5]. Human studies are limited by the difficulty in
obtaining consistent specimens suitable for rigorous exam-
ination. So far, information on the microarchitecture and
nanomechanical properties in response to Sr treatment in
large osteoporosis animal models is lacking.
Nanoindentation has been proven to be a powerful tool
for the measurement of local mechanical properties and is a
fairly mature technique for measurements in biological
tissues of the intrinsic material mechanical properties. This
method circumvents common limitations that arise when
applying large-scale mechanical testing techniques to
biological tissues [8–10]. With the help of nanoindentation,
measurement of localized changes due to enhanced or
inhibited bone mineralization and remodeling becomes
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(μCT) has been used to measure 3D bone structure of
animals due to its relative ease in sample preparation, its
noninvasive nature, and the high spatial resolution as
compared with conventional histology [11]. Studies have
demonstrated that μCT analysis of change patterns in 3D
bone parameters may serve as a valuable tool for the
evaluation of both anti-resorptive and anabolic agents in
ovariectomized (OVX) animals [12].
Low dosage of Sr was employed in this study as Sr at high
dosage may have deleterious effects on the bone [13–16]. For
instance, Sr at high dosage may induce rickets, a disease
characterized by the softening of bone, due simply to high
levels of this element in soil, together with the possible
contributions from the lack of sunshine and Ca dietary
deficiency [17, 18]. Since the main target populations for Sr
treatment are postmenopausal osteoporotic women who are
also susceptible to reduced renal function, the risk for
osteomalacia should be considered. Ca and P supplements
are added into the treatment regimen of Sr as the efficient
absorption of these two elements plays an essential role in
any increase in bone mass by forming osteoid and
hydroxyapatite, which compose the bulk of bones [19, 20].
In a previous study, we reported that Sr–Ca co-
administration stimulated new bone formation as
assessed by histomorphometry and molecular analysis
of gene expressions [21]. In this work, we aimed to
evaluate bone microarchitecture and nanomechanics at the
lumbar spine of skeletally mature OVX goats after Sr–Ca
co-administration for 16 weeks. The trabecular micro-
architectural parameters were quantified from μCT, while
the nanomechanical properties of single trabecula were




were ovariectomized by surgical procedures approved by the
local ethics committee to induce osteoporosis 1 year before
theevaluationwasinitiated.Themeanweightofthegoatswas
37.5 kg (range, 35–43 kg). The animals were then randomly
assigned into fourgroups: (1) the control group (n=3),(2) the
Ca group (n=5), (3) the Ca+24Sr group (n=5), and (4) the
Ca+40Sr group (n=5). All goats were fed with Rumilab Diet
5508 (Purina Mills, Richmond, IN, USA). Animals in the
control group were fed with the above feed with low
calcium. For animals in the treated groups, tricalcium
phosphate (TCP) and Sr-fortified tricalcium phosphate (Sr-
TCP) powder, synthesized by partially substituting Ca in
TCP with Sr, were supplied in the feed and administered
daily for 16 weeks. For animals in the Ca alone group, Ca
phosphate was supplied in the feed at the elemental dosage
of 100 mg kg
−1 day
−1. In addition to Ca supplementation, Sr
phosphate was supplied at 24 and 40 mg kg
−1 day
−1 to the
Ca+24Sr and Ca+40Sr groups, respectively. The detailed
treatment dosages are listed in Table 1. At 14 and 3 days
before killing, each animal was injected with 20 mg/kg
tetracycline (Terramycin, Pfizer) to obtain a double fluores-
cent label at the site of active bone formation. All animals
were killed at week 16 from the onset of treatment.
Serum Biochemistry
Blood samples were collected for Sr and Ca serum analysis
by aortic puncture right before killing. The serum samples
were prepared by acid digestion and the concentrations
determined by applying inductively coupled plasma–atomic
emission spectrometry (ICP-AES; iCAP 6300, Thermo
Jarrell Ash Co., USA).
Bone Mineral Content
The bone mineral content was measured in bone blocks
taken from the lumbar vertebrae (L2). The blocks were
washed with distilled water before dehydrated at 100°C for
24 h in an oven and calcinated at 600°C for 20 h. After
calcination, the bone ashes were then dissolved in 6 N HCl.
The Ca and Sr contents of the ashes were then determined
by ICP-AES (iCAP 6300, Thermo Jarrell Ash Co.).
Bone Specimen Preparation
Lumbar vertebrae (L1–L4) were harvested from the
fresh goat cadaver and freed of soft tissues. L3 was
f i x e di nM i l l o n i g ’s phosphate-buffered 10% formalin,
pH 7.4, at 4°C. After 24 h, transverse sections (1-cm
thickness) were prepared from the middle of each L3
vertebral body and dehydrated successively in 70%,
95%, and 100% ethanol before cleaning in xylene.
These undecalcified specimens were then embedded in
poly(methylmethacrylate) (PMMA).
Table 1 Groups and dosages of the experimental design
Groups Elemental dosages No. of goats
Ca (mg/kg/day) Sr (mg/kg/day)
Control 0 0 3
Ca 100 0 5
Ca+24Sr 100 24 5
Ca+40Sr 100 40 5
40 Z. Li et al.Specimen of L3 with PMMA embedding was processed
with a high-speed, water-cooled diamond saw (EXAKT
300 CP Band System, Norderstedt, Germany) to give
transverse sections of two different thicknesses: 3 mm and
40 μm. After being used for μCT test, the 3-mm-thick
sections were polished by sand paper with increasing
fineness from 240 to 1,200 grit and then further polished
on a micro-cloth with 6-, 1-, and 0.05-μma l u m i n a
suspension for μCT and the nanoindentation test. The
40-μm-thick sections were polished (EXAKT 400 CS
Micro Grinding System, Norderstedt, Germany) and
mounted for visualization by fluorescent microscopy
(Nikon H600L Microscope System, Japan).
New Bone Area Measurement
To measure the new bone formation, the new bone area
between the tetracycline labels in cancellous bone was
determined. On the unstained 40-μm-thick sections, double-
labeled bone areas (dL.Ari) were obtained and normalized to
trabecula area (in percent, dL.Ar/Tb.Ar) under fluorescent
microscopy (as shown in Fig. 1) on six representative fields
per bone sample. The representative tissue percentage
occupied by the double-labeled bone (dL.Ar/Tb.Ar) were








The measurement was 2D, confined to the spongiosa,
and made using a ×40 objective lens. Image analyses were
automatically performed with a program of Image Pro Plus
5.0 (Media Cybernetics, Inc. MD, USA).
Micro-CT Scanning
PMMA-embedded lumbar vertebrae (L3) were cut to
give 3-mm midshaft cross-sections for 3D data and
image acquisition using a desktop μCT system (μCT-40;
Scanco Medical, Bassersdorf, Switzerland). Micro-CT
scans were performed on the entire 3-mm specimen to
give 100 successive 30-μm slices. Scanning was per-
formed with the following parameters: 21-μm isotropic
voxel size, 55-keV voltage, 109-mA current, 200-ms
integration time, and 4,000 projections. Three-
dimensional information was obtained by stacking the
measured slices on top of each other. After digital
removal of the surrounding cortical bone, the entire
spongiosa was used for subsequent morphometric anal-
ysis. A representative 3D visualization of a complete
measurement is shown in Fig. 2. Bone volume fraction
(bone volume/total volume (BV/TV)), trabecular thickness
(Tb.Th), number (Tb.N), and separation (Tb.Sp) were also
evaluated. The connectivity density (Conn.D) was calcu-
lated using the Euler method [22].
Nanoindentation Test and Data Analysis
After assessment with the μCT test, the 3-mm-thick sections
were polished by sandpaper with increasing fineness (from
240 to 1,200 grit) and then further polished on a micro-cloth
with 6-, 1-, and 0.05-μm alumina suspension for the nano-
indentation test. The test was performed using a nanoindenter
equipped with a Beckovich tip (CSM Instruments SA,
Switzerland). For ease of comparison, a typical load-hold
scheme, with a peak load of 4 mN, loading rate 8 mN/min,
holding time 60 s, and unloading rate 10 mN/min, was used
for all the nanoindentation tests in this study. Five different
regions were selected for the nanoindentation tests to reduce
random errors, as shown in Fig. 3a. In each region, five
indents were made to calculate the elastic modulus and
hardness of nanoindentation (Fig. 3b, c). With the nano-
indentation technique, the most commonly used method for
data analysis is the Oliver–Pharr method [23], which
assumes that the tip–sample contact is purely elastic. Here,
we employed a method developed by Ngan et al. [24, 25]
that corrected for the viscoelastic effects during nano-
indentation measurements.
Statistical Analysis
All data were expressed as the mean±SD. The analysis
was performed with one-way analysis of variance. A
Fig. 1 Tetracycline double-labeled areas under fluorescent microsco-
py. Measurements of double-labeled surface area (dL.Ari) of selected
scope and the area of trabecular bone (B.Ari) were performed on six
representative fields for each sample. The result is given by percentage
of double-labeled area to bone area (dL.Ar/B.Ar)
Properties of Trabecular Bone After St Administration in Goats 41Student–Neuman–Keuls post hoc test was conducted on
the pooled data to determine the differences between the
groups at a significance level of p<0.05.
Results
Serum Biochemistry
The Sr serum concentrations before and after treatments are
shown in Fig. 4. No significant difference was observed
between the control and treated groups prior to treatment.
The mean serum Sr concentrations in the Ca group (2.44±
0.31×10
−3 mmol/l) and control group (3.34±0.12×
10
−3 mmol/l) were comparable. In contrast, the mean Sr
concentration in the Ca+24Sr and Ca+40Sr groups





As shown in Fig. 5, the Ca group (296±39 mg/kg) had
slightly decreased Sr concentrations in the lumbar vertebrae
compared with the control group (331±87 mg/kg). The
lumbar vertebrae Sr levels were increased to 1,133±341
and 1,834±417 mg/kg in the Ca+24Sr and Ca+40Sr
groups, respectively.
New Bone Area Measurement
In order to observe the anabolic effects of Sr, tetracycline
double-labeled areas (dL.Ar/B.Ar) were measured. In the
control and Ca treatment groups, the dL.Ar/B.Ar were
3.49±1.01% and 3.61±0.98%, respectively, and no
significant difference was observed. However, the dL.
Ar/B.Ar was significantly increased by 16.90% (p=
0.043) and 32.33% (p=0.037) in the Ca+24Sr and Ca+
40Sr groups, respectively.
Micro-CT Parameters of Lumbar Vertebral Body
Table 2 summarizes the effects of all treatments on 3D bone
microarchitecture parameters. Trabecular bone volume
fraction (bone volume/tissue volume, BV/TV) was signif-
icantly greater in the Ca+24Sr group compared with both
the control and Ca groups (+12.22% and +9.78%, p=0.010
and 0.0432, respectively). BV/TV was also significantly
greater in the Ca+40Sr group compared with both the
control and Ca groups (+22.78% and +20.11%, p=0.003
and 0.012, respectively). Tb.Th was significantly greater in
both Ca+24Sr and Ca+40Sr groups compared with the
control group (+21.84% and +32.76%, p=0.038 and 0.015,
respectively). Meanwhile, Tb.Th was significantly greater
in both Ca+24Sr and Ca+40Sr groups compared with the
Ca group (+13.98% and +24.19%, p=0.032 and 0.028,
Fig. 2 Representative Micro-
CT 3D image of cross-sectional
bone from the goat lumbar ver-
tebral body (L3). The micro-
architectures of the lumbar spine
of goats in the four different
groups are shown above
42 Z. Li et al.respectively). The decrease in Tb.N was accompanied with
an increase in Tb.Sp in response to treatment with Ca alone.
In contrast, in response to Sr–Ca treatment, Tb.N increased
while Tb.Sp decreased. The Conn.D was increased slightly
in Ca alone, while it was significantly greater in the Ca+
24Sr and Ca+40Sr groups (35.46% and 28.22%, p=0.029
and 0.034, respectively) compared with the control group.
Nanoindentation of Single Trabecula
The elastic modulus (E) and hardness (H) of the single
trabecula is shown in Table 3. The mean modulus of these
four groups was comparable and no significant difference
was observed. Although we observed a tendency for both
Ca alone and Ca combined with Sr to increase the elastic
Fig. 5 Strontium concentration in lumbar vertebra. Sr concentration
decreased slightly with Ca alone treatment; however, Ca–Sr co-
administration increased Sr levels significantly in both femur and
lumbar vertebra
Fig. 4 Strontium serum concentrations pre- and post-treatments. No
significant difference was observed between the control and treated
groups prior to treatment. Ca alone treatment decreased Sr level
marginally; in contrast, Sr concentrations increased considerably with
Ca–Sr co-administration
Fig. 3 Nanoindentation test
performed on single trabecula
of lumbar vertebra. a Nanoin-
dentation test was performed at
five different regions. b Indents
were performed on the junction
of trabeculae to prevent poten-
tial artifacts caused by intrinsic
bone defects. For each region,
six indents were performed, the
larger one for marking (b) and
the other five for data collection
(c)
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to be statistically significant. The E/H increased by 0.86%
(p=0.746) in the Ca-alone treatment group. In the Ca+24Sr
and Ca+40Sr groups, the E/H increased by 7.64% (p=
0.378) and 6.72% (p=0.122), respectively.
Discussion
The OVX goat is an acceptable animal model of osteopo-
rosis that allows a detailed study of the effects of therapies
at skeletal sites relevant to the treatment of osteoporosis
[26, 27]. In a previous study on OVX goats, we showed
that Sr–Ca co-administration significantly increased mineral
apposition rate and the osteoblast-related gene expression
(Runx2), demonstrating the anabolic effect of Sr–Ca
compound in the OVX goat model. However, it remains
unknown whether the Sr-mediated anabolic effect leads to
better trabecular bone microarchitecture and intrinsic bone
tissue properties. Our data presented here showed that Sr–
Ca co-administration significantly improved trabecular
bone mass and microarchitecture while not altering the
intrinsic bone tissue properties of trabecular bone.
The dosage of Sr treatment varied in a wide range in the
animal studies. In a recent study on OVX rats, Sr at the
dose of 25 mg kg
−1 day
−1 failed to exert anabolic effect on
the trabecular bone [28]. The effective dose of Sr treatment
in the animals ranged from 100 to 1,024 mg kg
−1 day
−1
[29–32]. The Sr dosages used in the present study were
lower than that in the previous animal studies [29–32], but
improved both static and dynamic bone histomorphometry
parameters as assessed by micro-CT and bone histomorph-
ometry, respectively. The higher bone volume is mainly due
to higher trabecular thickness, as there was no significant
change for trabecular number, suggesting that the main
anabolic effect of Sr is to thicken the existing trabeculae
instead of restoring trabecular number. To validate the
anabolic effect of Sr on bone at the tissue level, we
evaluated the dynamic bone formation parameter using
double fluorescence labeling. The dynamic bone formation
parameter such as the double-labeled new bone area was
significantly higher in the Sr–Ca compound group com-
pared with the Ca or control groups. These data from the
micro-CT and bone histomorphometry reflect that the
activity of osteoblasts/progenitors in bones has increased
after Sr–Ca compound treatment.
Calcium supplementation alone did not change the
serum or bone Ca levels, but did result in a marginally
decreased serum and bone Sr concentrations. This may be
due to the competitive effect between Sr and Ca which
share similar physical and chemical properties. Further-
more, the bone mineral content assay indicated that Sr was
taken up by the bone matrix in cancellous (lumbar
vertebrae) bone in a dose-dependent manner. Even though
Sr content significantly increased, the level of Ca was not
considerably changed since the amount of Ca was much
higher than the trace element Sr.
Bone strength is determined not only by bone geometry,
cortical bone thickness, porosity, and trabecular bone
microarchitecture but also by the intrinsic bone tissue
property. The effect of Sr treatment on bone mineral
density, volume, and microarchitecture has been intensively
investigated in a number of studies. Very little information
on the effect of Sr on intrinsic bone tissue quality is
available [1]. By the nanoindentation test, we demonstrated
that there were no significant changes for both elastic
modulus and hardness in trabecular bone in Sr treatment
and Ca or control groups. These results are consistent with
Parameter Groups
Control Ca Ca+24Sr Ca+40Sr
BV/TV 0.180±0.006 0.184±0.009 0.202±0.013*
,** 0.221±0.017*
,**
Tb.Th (mm) 0.174±0.016 0.186±0.020 0.212±0.025*
,** 0.231±0.031*
,**
Tb.Sp (mm) 0.474±0.062 0.519±0.135 0.435±0.048 0.432±0.045
Tb.N (1/mm) 2.337±0.593 2.123±0.656 2.559±0.432 2.618±0.530
Conn.D (1/mm
3) 3.154±0.791 3.419±0.862 3.789±1.010* 4.003±1.208*
Table 2 Microarchitecture
parameters of lumbar vertebral
body of goats in control and
experimental groups
*p<0.05 (vs. control group);
**p<0.05 (vs. Ca group)
Group Elastic modulus, E (GPa) Hardness, H (MPa) E/H
Control 14.025±0.017 685.800±37.937 20.790±0.707
Ca 14.052±1.102 670.146±62.170 20.970±0.461
Ca+24Sr 14.017±0.297 639.959±63.869 22.378±2.100
Ca+40Sr 13.542±0.665 642.025±28.620 22.187±0.720
Table 3 Elastic modulus
(E) and hardness (H) of single
trabecula
44 Z. Li et al.the recent report that showed no significant difference for
elastic modulus between placebo and Sr ranelate group in
postmenopausal women [33]. The condition for the samples
(dry or wet) plays an essential role on the determination of
effect of Sr treatment on elastic modulus or hardness. As in
another study, significant effects of Sr treatment on the
elastic modulus, hardness, and dissipated energy are only
observed in the vertebrae samples in physiological (hydrated)
but not in dry conditions [1]. The reason for the failure to
observe the obvious effect of Sr treatment on intrinsic tissue
quality at dry conditions remains unknown. One of the
possible reasons is that in the bone mineral phase, Sr is
mainly located in the hydrated layer and could potentially
structurally modify the bone matrix in relation to the
hydration state of the bony tissue.
In this study, hardness in all treatment groups was lower
compared with the control group, and the differences were
not statistically significant. Indentation hardness of the
bone depends heavily on the degree of bone mineralization
[34]. Under the influence of the anabolic effect of Sr, the
slight decrease in bone hardness may result from the
enhanced formation of a less mineralized new bone. E/H
is useful in the evaluation of the overall deformation
characteristics during indentation and is proportional to
the fracture toughness of the bone [35]. Higher E/H values
correspond to a more ductile material, while lower E/H
values generally indicate a more brittle material. Upon
treatment with Sr, a considerably higher E/H ratio, without
statistical significance, was observed.
The result of a large animal model will show more
clinical relevance than that of rodents, but there are still
some limitations in the current study, such as the relatively
small sample size compared with small animal studies.
Increasing the sample size in each group may provide more
valuable statistical representation for the data. The hardness
and modulus of a single trabecula were determined in
dehydrated sample, which was different from physiological
conditions. Obviously, more work has to be conducted on
fresh samples to guarantee the elucidation of the Sr
treatment on the nanomechanical properties of bone.
In conclusion, our findings showed that Sr treatment
stimulated new bone formation and also improved bone
microstructure in osteoporotic goats as measured by μCT.
Sr treatment significantly increased trabecular bone volume
primarily by increasing trabecular thickness, but the nano-
mechanical properties of a single trabecula were not altered.
The results suggested that the reduced osteoporotic fracture
risk was mainly due to the improvement in bone micro-
architecture instead of the intrinsic tissue properties of a
single bone unit.
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